A double-blind, placebo-controlled study of alpidem, a novel anxiolytic of imidazopyridine structure, in chronically anxious patients.

Source:http://linkedlifedata.com/resource/pubmed/id/2572145

Download in:

View as

General Info

PMID
2572145